On March 8th, 2021, FDA is hosting a public meeting on Patient-Focused Drug Development for Vitiligo. FDA is interested in hearing patients’ perspectives on the impact of vitiligo on daily life and patient views on treatment approaches.
Copyright © 2024 | WordPress Theme by MH Themes